Targeted News Service logo

Alliance Advocates for Equitable Access for Alzheimer's Patients Seeking New Treatment

WASHINGTON, March 18 (TNStalk) -- The Alliance for Aging Research issued the following statement on March 17, 2023:

* * *

The Institute for Clinical and Economic Review (ICER) held a meeting today to discuss Leqembi (lecanumab), an FDA-approved treatment that slows cognitive decline in patients with early-onset Alzheimer's disease. Alliance President & CEO Sue Peschin, MHS, gave public comment during the meeting:

Hello, everyone. I'm Sue Peschin. I serv . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial
Keywords or
Areas of Interest:
Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted:
Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial